Read + Share
Amedeo Smart
Independent Medical Education
Long GV, Larkin J, Schadendorf D, Grob JJ, et al. Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma. J Clin Oncol 2024 Nov 6:JCO2400400. doi: 10.1200/JCO.24.00400.PMID: 39504507
Email
LinkedIn
Privacy Policy